Inventor · disambiguated record
Rebecca Urbanek
Also filed as: URBANEK REBECCA · URBANEK REBECCA A · URBANEK REBECCA ANN
12 granted patents·16 pending applications·29 citations·filing 2000–2011
86Inventor score
Top patents by PatentIndex Score
28 records- 0186US7868008B2Substituted isoindolones and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2006·Granted Jan 11, 2011·11 cites·4 claims
- 0282US7807706B2Metabotropic glutamate-receptor-potentiating isoindolonesASTRAZENECA AB·Filed 2006·Granted Oct 5, 2010·6 cites·9 claims
- 0381US7968570B2Isoindolone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2005·Granted Jun 28, 2011·6 cites·4 claims
- 0470US6787547B2Compound and method for the treatment of painASTRAZENECA AB·Filed 2000·Granted Sep 7, 2004·3 cites·7 claims
- 0568US6730675B2Compounds and methods for the treatment of painASTRAZENECA AB·Filed 2003·Granted May 4, 2004·2 cites·10 claims
- 0660US6943165B2Compound and method for the treatment of painASTRAZENECA AB·Filed 2004·Granted Sep 13, 2005·0 cites·16 claims
- 0757US7842803B2Nicotinic acetylcholine receptor ligands 101ASTRAZENECA AB·Filed 2007·Granted Nov 30, 2010·0 cites·4 claims
- 0857US6933297B27-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione and the use thereof for the treatment of painASTRAZENECA AB·Filed 2001·Granted Aug 23, 2005·1 cites·4 claims
- 0950US2005227977A1Substituted 1,2,5,10-tetrahydropyridazino [4,5-b]quinoline-1,10-dione compounds and methods for the treatment of painASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 1048US2009215841A1D2 Receptor Ligand-078ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1144US2009076064A1CompoundsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1243US2011166155A1Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor PotentiatorsVAN WAGENEN BRADFORD·Filed 2011·Application pending·0 cites
- 1342US6946463B21,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of painASTRAZENECA AB·Filed 2001·Granted Sep 20, 2005·0 cites·8 claims
- 1442US2003181449A1Methods and compositions for the treatment of painFiled 2000·Application pending·0 cites
- 1541US2009192169A1Bicyclic Benzimidazole Compounds and Their Use as Metabotropic Glutamate Receptor PotentiatorsEGLE IAN·Filed 2007·Application pending·0 cites
- 1641US2011136804A1Nicotinic Acetylcholine Receptor Ligands 101ASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 1740US6833368B21, 2, 5, 10-tetrahydropyridazino[4, 5-b]quinoline-1,10-diones and their use for the treatment of painASTRAZENECA AB·Filed 2001·Granted Dec 21, 2004·0 cites·9 claims
- 1840US2009069340A1Pyrazolone Compounds As Metabotropic Glutamate Receptor Agonists For The Treatment Of Neurological And Psychiatric DisordersASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 1940US2005124622A1Compounds and methods for the treatment of painFiled 2000·Application pending·0 cites
- 2039US2003176435A1Compounds and methods for the treatment of painFiled 2000·Application pending·0 cites
- 2139US2008269275A1Novel Mchr1 Antagonists and Their Use for the Treatment of Mchr1 Mediated Conditions and DisordersASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2238US2003130298A1Cd45 inhibitorsFiled 2000·Application pending·0 cites
- 2337US8153638B2Metabotropic glutamate-receptor-potentiating isoindolonesVAN WAGENEN BRADFORD·Filed 2010·Granted Apr 10, 2012·0 cites·3 claims
- 2435US2005070544A11,2,5,10-tetrahydropyridazino{4,5-b}quinoline-1,10-diones and their use for the treatment of painASTRAZENECA AB·Filed 2001·Application pending·0 cites
- 2533US6939896B2Cd45 inhibitorsASTRAZENECA AB·Filed 2000·Granted Sep 6, 2005·0 cites·3 claims
- 2633US2003162783A1Method and composition for the treatment of painFiled 2000·Application pending·0 cites
- 2733US2003153571A1Method and composition for the treatment of painFiled 2000·Application pending·0 cites
- 2830US2003207812A1Cd45 inhibitorsFiled 2000·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →